NCT03692377

Brief Summary

Children who present to the emergency department often require painful procedures (intravenous catheterization, laceration repair, fracture reduction, etc.). Virtual reality (VR) has been presented as a way of managing pain and anxiety in children undergoing painful procedures but most studies are limited to children 6 or older. The present study seeks to determine the youngest age (2-6) of future subjects in research of VR and clinical care. Virtual Reality is an immersive experience using sight, sound, and position sense. Using VR may enhance distraction during the painful procedure and may reduce attention to pain. Investigators will instruct and observe children age 2-6 in using a VR device and document how easy the device is to use for the child. The children will have the opportunity to select an application and play with the device for 10 minutes before being asked about their experience with the device. Parents/Guardians will also be asked about their child's experience with the device.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 20, 2018

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 2, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

November 9, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 21, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 21, 2019

Completed
Last Updated

January 18, 2019

Status Verified

January 1, 2019

Enrollment Period

11 months

First QC Date

September 20, 2018

Last Update Submit

January 16, 2019

Conditions

Keywords

Virtual Reality

Outcome Measures

Primary Outcomes (1)

  • Usability in Stage 4 (Applying the headset on the eyes of the child with software application) as measured by a five point scale.

    The research assistant will assess how the child reacts to wearing VR as measured by a five point scale: 1. \- Child tries to use the headset themselves with no help 2. \- Child helps the research assistant to put the headset on their face 3. \- Child is passive while the research assistant to put the headset on their face 4. \- Child resist by pushing the research assistant's hands 5. \- Child significantly resist/ cry/ wave arms / push feet

    Recorded during Stage 4 of the procedure

Secondary Outcomes (6)

  • Time of demonstration required by child measured in seconds

    Recorded during Stage 1 of intervention, before child puts headset on. Up to 120 seconds.

  • Mood/Behaviors during Handling of VR rated 1-100 on a Visual analogue scale

    Recorded during Stage 3 of intervention. Up to 1 minute while child handles and puts on headset.

  • Time using VR in minutes

    Recorded during Stage 5 of the procedure. Up to 10 minutes.

  • Willingness to Return VR as measured by a three point scale

    Recorded during Stage 6 of the procedure

  • Patient experience questions as measured by a 4 point scale and open ended question

    Immediately after the intervention (within 10 minutes)

  • +1 more secondary outcomes

Study Arms (1)

Children Aged 2-6

Children 2 to 6 years of age who are arriving with a guardian to the Emergency Department with a low acuity condition (Canadian Triage scale (CTAS) 4 or 5) and are waiting to be seen by the doctor, or are waiting for test results.

Device: Virtual Reality

Interventions

Stage 1 : Demonstration of the use of the VR headset by the research assistant (anticipated 1-2 min) Stage 2 : Child will choose the application they would like to see - they will be shown 3 pages of the three applications offered - see Fig 1 (anticipated 1-2 min) Stage 3 : Handling of the VR headset by the child (anticipated 1 min) Stage 4 : Applying the headset on the eyes of the child with software application (anticipated 1 min) Stage 5 : The child use the VR set and application (up to 10 minutes) Stage 6 : Removal of the headset (anticipated 1 min) Stage 7 : Questionnaire to child (interview - 2 minutes) Stage 8 : Questionnaire to parents/guardians (interview - 2 minutes)

Children Aged 2-6

Eligibility Criteria

Age2 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children 2 to 6 years of age who are arriving with a guardian to the Emergency Department with a low acuity condition (Canadian Triage scale (CTAS) 4 or 5) and are waiting to be seen by the doctor, or are waiting for test results.

You may qualify if:

  • Children age 2-6 years of age
  • Patients arrived with a legal guardian to the emergency department
  • Parents will sign a consent form and children will agree verbally to participate
  • Triage category 4 or 5 (lowest acuity)

You may not qualify if:

  • Children with conditions that may prohibit participation or evaluation of the procedure (such as developmental delay, autism, neurological or other condition limiting communication)
  • Facial features or injury prohibiting wearing the VR goggles
  • Painful procedures in the emergency before being approached (such as blood testing, IV, catheterization, immunization, laceration repair)
  • Child is suffering pain or distress at a level that prohibit focusing on the study for 20 minutes, as assessed by the research assistant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BC Children's Hospital

Vancouver, British Columbia, V6H 3N1, Canada

RECRUITING

Study Officials

  • Ran Goldman, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ran Goldman, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Co-head of the Division of Clinical Pharmacology, Division of Emergency Medicine, Department of Pediatrics; Investigator, BC Children's Hospital

Study Record Dates

First Submitted

September 20, 2018

First Posted

October 2, 2018

Study Start

November 9, 2018

Primary Completion

September 21, 2019

Study Completion

September 21, 2019

Last Updated

January 18, 2019

Record last verified: 2019-01

Locations